Palisade Bio (PALI) Return on Sales Growth (5y) (2016 - 2023)

Palisade Bio (PALI) Return on Sales Growth (5y) (2016 - 2023) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Palisade Bio 985.76 -132.63 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2023 519.00
Sep 30, 2023 629.00
Jun 30, 2023 -193.00
Mar 31, 2023 817.00
Sep 30, 2022 -6,343.00
Jun 30, 2022 -1,598.00
Mar 31, 2022 -4,482.00
Dec 31, 2020 604.00
Sep 30, 2020 1,517.00
Jun 30, 2020 1,420.00
Mar 31, 2020 1,331.00
Dec 31, 2019 330.00
Sep 30, 2019 24.00
Jun 30, 2019 1,106.00
Mar 31, 2019 430.00
Dec 31, 2018 607.00
Sep 30, 2018 1,846.00
Jun 30, 2018 2,493.00
Mar 31, 2018 -935.00
Dec 31, 2017 1,077.00